AI Insight
The EVAOLD trial, presented at ESC Congress 2026, found that older patients experiencing the most common type of heart attack should continue to receive a routine invasive treatment approach rather than switching to a more selective strategy. The study provides clinical guidance specifically for managing heart attack treatment in elderly patient populations. The findings support maintaining current standard invasive protocols for older patients rather than adopting a more conservative treatment selection process.
Why it matters
This research has direct implications for cardiology practice by clarifying treatment protocols for a vulnerable and growing demographic of older heart attack patients. The results will help physicians make evidence-based decisions about whether to pursue aggressive interventional treatments in elderly patients, potentially affecting outcomes and quality of care for this age group.
Understand the Science
A routine invasive approach should not be replaced with a more selective approach in older patients with the most common type of heart attack. This was the main finding of the EVAOLD trial presented in a Hot Line session today at ESC Congress 2026.
Source: EVAOLD trial provides guidance on treating older patients after a heart attack